Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2013-09, Vol.120 (9), p.1944-1945.e1
Hauptverfasser:	Tufail, Adnan, MD, FRCOphth, Narendran, Nirodhini, MD, FRCOphth, Patel, Praveen J., MBBS, FRCOphth, MD(Res), Sivaprasad, Sobha, DM, FRCS, Amoaku, Winfried, MBBS, FRCOphth, Browning, Andrew C., BM, FRCOphth, Osoba, Olayinka, MBBS, FRCS(Ed), Gale, Richard, MBBS, MRCP, MRCOphth, George, Sheena, MBBS, FRCOphth, Lotery, Andrew J., MD, FRCOphth, Majid, Mohammed, MBBS, FRCOphth, McKibbin, Martin, MBBS, FRCOphth, Menon, Geeta, MBBS, FRCOphth, Andrews, Christopher, CStat, Brittain, Christopher, MBBS, MRCOphth, Osborne, Aaron, MBBS, MRCOphth, Yang, Yit, MBChB, FRCOphth
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Choroidal Neovascularization - diagnosis Choroidal Neovascularization - drug therapy Choroidal Neovascularization - etiology Female Follow-Up Studies Humans Intravitreal Injections Male Middle Aged Myopia, Degenerative - complications Myopia, Degenerative - diagnosis Myopia, Degenerative - drug therapy Ophthalmology Prospective Studies Ranibizumab Tomography, Optical Coherence Treatment Outcome Visual Acuity - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!